Skip to main content
. 2021 Nov 22;12:761354. doi: 10.3389/fimmu.2021.761354

Table 1.

Clinical features, auxiliary examinations, diagnosis and treatment strategies, prognosis in pediatric patients positive for GFAP-IgG.

Patient no. Sex/age of onset Summary clinical MRI EEG Serum antibody CSF abnormality Therapy Response To therapy mRS at onset/last Once lived in ICU
1.M/11.75 vertigo T2-hyperintense lesions in white matter around
posterior horn of bilateral lateral ventricles
normal GFAP-IgG(1:32) Wbc:3
P:0.18
Antibody (-)
Prednisone no change of lesions 1/0 No
2.F/1.67 Fever, dyskinesia Space occupying lesions in suprasellar region Combined supratentorial hydrocephalus normal GFAP-IgG(1:100) WBC:1
P:0.26
Antibody:NA
Surgery + biopsy Brain glioma, death 4/5 No
3.M/2.75 epilepsy(Focal attack) T2-hyperintense lesions in midbrain, cerebral foot, dorsal thalamus, basal ganglia and temporal lobe, Slow background,left temporal sharp wave GFAP-IgG(1:100) WBC:8
P:0.07
Antibody (-)
IVIG,IVMP,AEDS Brain glioma, aggravated 3/5 No
4.F/6.33 vertigo T2-hyperintense lesions in bilateral subcortical white matter of frontal, temporal,parietal lobes NA GFAP-IgG(1:100) WBC:2
P:0.11
Antibody (-)
IVIG,IVMP no change of lesions 2/0 No
5.M/12.41 epilepsy T2-hyperintense lesions in parasylvian cistern of right parietal lobe, left frontal lobe right parietal, left frontal
sharp wave
GFAP-IgG(1:32) WBC:3
P:0.412
Antibody (-)
IVIG,IVMP no change of lesions 2/0 No
6.F/4 psychosis T2-hyperintense lesions and enhancement in frontal,parietal lobe, thalamus, midbrain Slow background GFAP-IgG(1:32) WBC:8
P:0.25
Antibody (-)
IVIG,IVMP Symptoms disappeared,
Lesion reduced
1/0 No
7.M/11 Limb numbness,
Dyskinesia,ataxia
SC:C2-4 Normal GFAP-IgG(1:32) WBC:4
P:0.14
Antibody (-)
IVIG,IVMP Symptoms improved,
Lesion reduced
4/1 No
8.M/2.17 epilepsy(Focal attack) T2-hyperintense lesions in left temporal,occipital lobe Slow background,left temporal,occipital sharp wave GFAP-IgG(1:32)
after 6 month:GFAP-IgG(1:100)
WBC:55
P:0.13
Antibody (-)
IVIG,IVMP,AEDS Seizure frequency decreased,
cognitive impaired.
Lesion reduced
2/0 No
9.M/2 ataxia,
Relapse 2 times
T2-hyperintense lesions in white matter around left lateral ventricle Slow background GFAP-IgG(1:32) WBC:32
P:0.19
Antibody :NA
IVIG,IVMP Retroperitonea-l ganglioma.
Lesion reduced
4/1 No
10.M/10.25 Headache,right optic neuritis,
Relapse 1 times
T2-hyperintense lesions and enhancement of right optic nerve normal GFAP-IgG(1:32) WBC:0
P:0.25
Antibody (-)
IVMP Symptoms improved,
Lesion reduced
3/0 No
11.M/6 Fever, epilepsy,
psychosis,
hypersomnia
T2-hyperintense lesions in bilateral thalamus,frontal, temporal, parietal lobes. Slow background GFAP-IgG(1:32) WBC:2
P:0.18
Antibody :NA
IVMP Symptoms disappeared,
Lesion disappeared
3/0 Yes
12.M/10.41 Fever, headache,
psychosis,
hypersomnia, epilepsy,
dyskinesia
T2-hyperintense lesions in parietal lobe, occipital lobe, corpus callosum Slow background,occipital and posterior temporal electric attack GFAP-IgG(1:100) WBC:5
P:0.18
Antibody (-)
IVIG,IVMP,AEDS Symptoms disappeared,
Lesion reduced
5/1 Yes
13.M/8.41 Fever, headache T2-hyperintense lesions in bilateral subcortical white matter of frontal,parietal lobes Slow background GFAP-IgG(1:100) WBC:1 P:0.13
Antibody :NA
IVMP Symptoms disappeared,
Lesion reduced
2/0 No
14.F/8.08 Headache,
psychosis,
Relapse 1 times
T2-hyperintense lesions in bilateral thalamus,temporal lobes. Slow background GFAP-IgG(1:32) 1.WBC:2 P:0.164
2.WBC:72
P:0.167
Antibody (-)
IVIG,IVMP Symptoms disappeared,
Lesion reduced
2/0 No
15.F/1.92 Fever, headache,hypersomnia T2-hyperintense lesions in
bilateral thalamus, cerebral peduncle, dorsal pons, cerebellar dentate nucleus and left frontal lobe.
SC:lesions and mild enhancement in C3-6
Slow background GFAP-IgG(1:32) Wbc.231
P.0.47
Antibody :NA
IVIG,IVMP Symptoms disappeared,
Lesion disappeared
2/0 No
16.M/10.58 After mumps,fever, headache,vomit T2-hyperintense lesions in corpus callosum Slow background GFAP-IgG(1:100) wbc:550
P:0.34
Antibody (-)
IVIG Symptoms disappeared,
Lesion disappeared
1/0 No
17.M/2 Fever, headache, epilepsy,
psychosis,
hypersomnia,
Dyskinesia,Autonomic nerve dysfunction
Demyelinating changes in frontal, parietal, occipital, temporal, cerebellum, brainstem, basal ganglia, thalamus and corpus callosum.
Mild enhancement of basal ganglia lesions.Periventricular radial linear enhancement.
Slow background,frontal, central, temporal spike wave GFAP-IgG(1:10) Wbc:55
P:0.29
Antibody (-)
IVIG,IVMP Symptoms improved,
Lesion reduced,
cognitive, Movement, language impaired.
5/4 Yes
18.F/4.75 right optic neuritis,right limb numbness,
Relapse 2 times
Lesions in right optic nerve Normal 1.MOG (1:100) GFAP( 1:32)
2.MOG (1:320) GFAP( 1:100)
WBC:80
P:0.21
MOG-IgG (1:100)
IVIG,IVMP,Rituximab Symptoms improved,
Lesion disappeared
2/1 No
19.F/5.67 dyskinesia Enhancement of the anterior root of spinal cord below T 12 Normal GM1 IgM、GM2 IgM、GFAP-IgG(1:32) WBC:1
p:0.94
Antibody :NA
IVMP Symptoms improved,
Lesion disappeared
4/3 No
20.M/10.67 Optic neuritis,vertigo Lesions in bilateral optic nerve, optic chiasm, optic tract normal MOG-IgG(1:10)、
GFAP-IgG(1:32)
WBC:6
P:0.24
Antibody (-)
IVMP Symptoms improved,
Lesion disappeared
2/1 No
21、F/9 Fever, headache,
hypersomnia, Optic neuritis,
dyskinesia,dysuria,Autonomic nerve dysfunction.
Relapse 5 times
T2-hyperintense lesions in brainstem,lateral ventricle, bilateral optic nerve,
Sc:C3-6,T1-10
Enhancement around lateral ventricle
Slow background AQP4-IgG(1:32) 、GFAP-IgG(1:32) WBC:40
P:0.23
AQP4-IgG(1:320)
IVIG,IVMP,Azathioprine,Rituximab recurrence 5/3 No
22.M/1.58 Fever,
hypersomnia,
ataxia, dyskinesia,
tumor
T2-hyperintense lesions in blateral midbrain, dorsal thalamus, basal ganglia, bilateral cerebral hemispheres, pons and medulla oblongata
SC :Cervical spinal cord and below T8
NA YO IgG、GFAP-IgG(1:100) WBC:25; p:0.41
Antibody :NA
IVIG,IVMP Symptoms improved,
Lesion disappeared
4/1 No
23.M/13.17 Fever, headache,
hypersomnia, seizures,
Optic neuritis,
left limb dyskinesia,left peripheral facial paralysis,limited abduction of left eyeball,
Relapse 1 time
T2-hyperintense lesions in frontal, temporal, parietal, occipital and left optic nerves.
strip enhancement in left optic nerves and partial sulcus of bilateral cerebral hemispheres.
Slow background 1.MOG-IgG(1:32) 、
2.GFAP-IgG(1:32)
MOG-IgG(1:100)
WBC:360 P:0.2
MOG-IgG(1:32)
IVIG,IVMP+Rituximab Symptoms improved,
Lesion disappeared
5/2 No
24.F/12.25 Fever, psychosis,
hypersomnia, seizures,
T2-hyperintense lesions in right temporal, parietal,occipital and thalamus Slow background NMDAR-IgG(1:10) 、
GFAP-IgG(1:100)
WBC:37 P:0.15
NAMDR-IgG(1:10)
IVIG,IVMP Symptoms disappeared,
Lesion disappeared
4/1 No
25.M/9.25 psychosis,
hypersomnia, seizures,
T2-hyperintense lesions in white matter of right parietal lobe, bilateral basal ganglia, thalamus NA NMDAR-IgG(1:10)、GFAP-IgG(1:32) WBC:120
P:0.21
NMDAR-IgG(1:30)、GFAP(1:32)
IVIG,IVMP Symptoms improved,
Lesion reduced
5/3 No
26.M/11 epilepsy(Focal attack) T2-hyperintense lesions in right part of cerebral cortex and right optic nerve.
Gyrus like enhancement in partial sulcus of right frontal, temporal, parietal and occipital lobes.
Slow background, right temporal
Sharp wave
NMDAR-IgG(1:10)、MOG-IgG(1:100) WBC:28
P:0.21
NMDAR-IgG(1:1)、MOG-IgG(1:100)、GFAP-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion disappeared
1/0 No
27.F/5.67 headache,
psychosis,
hypersomnia, visual ghosting
T2-hyperintense lesions in cerebellar parenchyma, brain stem, thalamus, some cerebral hemispheres,right optic nerve.
Enhancement of hippocampus and optic nerve.
SC:C2-C7、T8-T12.
Slow background MOG-IgG(1:10) WBC:26
P:0.15
GFAP-IgG(1:32)、NMDAR-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion reduced
3/0 No
28.M/3.08 Fever, headache,
hypersomnia,
weakened knee reflex, ptosis, ataxia
T2-hyperintense lesions and enhancement in bilateral basal ganglia, thalamus and brainstem, bilateral cerebellar hemispheres.
Strip enhancement of
bilateral temporal, parietal, occipital meninges
Slow background GFAP-IgG(1:32)、GM1-IGM WBC:180
P:0.751
GFAP-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion reduced
4/0 No
29.F/3.58 Fever, headache T2-hyperintense lesions in Bilateral cerebral hemispheres, around the fourth ventricle, cerebellum, brain stem white matter and sacrococcygeal meninges.
SC :Sacrococcygeal meningeal enhancement
Slow background Antibody (-) WBC:341
P:0.4
GFAP-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion reduced
2/1 No
30.M/7 Fever, nausea, vomiting, dizziness T2-hyperintense lesions in white matter of Bilateral frontal parietal lobe, bilateral basal ganglia, thalamus and corpus callosum Slow background GFAP-IgG(1:32) WBC:18
P:0.45
GFAP-IgG(1:320)
IVIG,IVMP Symptoms disappeared,
Lesion reduced
2/1 Yes
31.M/1.33 Fever, seizures,hypersomnia,dyskinesia T2-hyperintense lesions in Bilateral Cerebral lobe and cerebellum, brain stem and corpus callosum
Meningeal enhancement, periventricular atrophy and right frontal subdural effusion
Slow background,occipital sharp wave Antibody (-) WBC:50
P:0.60
GFAP-IgG(1:32)
IVIG,IVMP,AEDS Symptoms improved,
Lesion reduced,
cognitive, Movement, impaired.
5/4 Yes
32.M/5.58 Fever,headache,vomiting Normal normal GFAP-IgG(1:32) WBC:600
P:0.85
GFAP-IgG(1:32)
IVIG Symptoms disappeared 1/1 No
33.F/7.41 Fever, headache, hypersomnia,
psychosis, seizures,
dyskinesia,dysuria
T2-hyperintense lesions and enhancement in bilateral frontal,parietal, occipital cortex and white matter, basal ganglia, thalamus and periphery of the fourth ventricle.
Meningeal enhancement of basal cistern and diffuse enhancement of meninges.
SC:lesion and enhancement in
T1-L1,Strip enhancement of spinal meninges
Slow background GFAP-IgG(1:100) WBC:240
P:1.56
GFAP-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion disappeared
5/1 Yes
34.F/4.08 Fever, hypersomnia,
psychosis,Involuntary action
T2-hyperintense lesions in Bilateral dorsal thalamus and basal ganglia, bilateral frontal parietal white matter and corpus callosum NA Antibody (-) WBC:55
P:0.88
GFAP-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion disappeared
4/1 Yes
35.M/1.67 Fever,seizures,dyskinesia, coma,peripheral motor nerve damage T2-hyperintense lesions in bilateral cerebral cortex, subcortical and thalamus Slow background GFAP-IgG(1:10) WBC:16
P:0.53
GFAP-IgG(1:1)
IVMP Symptoms improved,
Lesion reduced,
cognitive, Movement, impaired.
5/4 Yes
36.M/4.25 Fever, headache, hypersomnia,
psychosis, hyperhidrosis
T2-hyperintense lesions in bilateral thalamus, frontal and temporal lobes.
Leptomeningeal enhancement of cerebrum
Slow background GFAP-IgG(1:32) WBC:420
P:1.235
GFAP-IgG(1:32)
IVIG,IVMP Symptoms disappeared,
Lesion disappeared
2/1 No
37.M/7.5 Nephrotic syndrome was diagnosed for 5 years.
Fever, psychosis, seizures,coma,dysuria
T2-hyperintense lesions in bilateral cerebral cortex and subcortical white matter, bilateral paraventricular white matter.
Linear and arc enhancement of bilateral cerebral sulcus and bilateral forehead
Diffuse low voltage GFAP-IgG(1:32) WBC:2
P:0.05
GFAP-IgG(1:32)
IVMP,ADES,Tacrolimus Symptoms improved,
Lesion reduced,
cognitive, Movement, impaired,epilepsy
5/4 Yes
38.M/3.75 Fever, psychosis, seizures,coma,urinary retention,optic neuritis, T2-hyperintense lesions in white matter of bilateral cerebral hemispheres, bilateral basal ganglia, thalamus and fourth ventricle.
Periventricular radial linear
enhancement.
Leptomeningeal enhancement of bilateral occipito parietal lobes.
Slow background,frontal sharp wave GFAP-IgG(1:32) WBC:400
P:0.63
GFAP-IgG(1:100)
IVIG,IVMP Symptoms disappeared,
Lesion reduced,
5/3 Yes
39.M/1.17 Right peripheral facial paralysis T2-hyperintense lesions in white matter around bilateral lateral ventricles NA GFAP-IgG(1:1000) WBC:2
P:0.30
GFAP-IgG(1:100)
IVIG Symptoms improved,
Lesion reduced
2/1 No
40.M/10.75 Fever, psychosis, seizures, coma, dyskinesia, hyponatremia, peripheral nerve injury T2-hyperintense lesions and
enhancement in bilateral basal ganglia, caudate nucleus, thalamus, brainstem and cerebellar dentate nucleus.
SC:lesions and enhancement in Spinal cord (mainly cervical and thoracic cord).
Strip enhancement of meninges in spine and meninges in basal cistern.
Slow background Antibody (-) Wbc:382,P:0.84
GFAP-IgG(1:32)
IVIG,IVMP,PLEX Symptoms improved,
Lesion reduced, cognitive, Movement, impaired.
5/3 Yes

M, male, F, female; N, normal; NA, no available; AED, antiepileptic drug; CSF, cerebrospinal fluid; EEG, electroencephalography; MRI, magnetic resonance imaging; mRS, modified Rankin Scale. IVIG, intravenous immunoglobulin; IVMP, intravenous methylprednisolone; PLEX, Plasma exchange;AQP4, aquaporin-4; MOG, myelin oligodendrocyte glycoprotein; NMDAR, N-methyl-d-aspartate receptor; GM, monosialotetrahexosylgangliosid.